Prognostic value of inflammatory markers in predicting recurrence-free survival in gastrointestinal stromal tumor patients: A nomogram-based approach

doi:10.4251/wjgo.v17.i2.94956

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (916)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

HTML

528

Figures (1-3)

136

Tables (1-6)

109

Sum=804

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=65

Feb 15, 2025 (publication date) through Apr 3, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Feb 15, 2025; 17(2): 94956
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.94956

Full Size Figure Download Figure

Figure 2 Recurrence-free survival curves for monocyte/Lymphocyte ratio, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, systemic immune-inflammation index and targeted therapy. A: Systemic immune-inflammation index; B: Neutrophil/lymphocyte ratio; C: Monocyte/lymphocyte ratio; D: Platelet/lymphocyte; E: Targeted therapy. SII: Systemic immune-inflammation index; NLR: Neutrophil/lymphocyte ratio; PLR: Platelet/lymphocyte ratio; MLR: Monocyte/lymphocyte ratio; RFS: Recurrence-free survival.

Citation: Zhao JL, Wang MY, Lv YZ, Zhou YJ. Prognostic value of inflammatory markers in predicting recurrence-free survival in gastrointestinal stromal tumor patients: A nomogram-based approach. World J Gastrointest Oncol 2025; 17(2): 94956
URL: https://www.wjgnet.com/1948-5204/full/v17/i2/94956.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.94956